Evidence review
Semaglutide vs Tirzepatide: The Cheaper Effective GLP-1
Tirzepatide loses more weight in trials, but semaglutide costs less. Here's how to decide which GLP-1 gives you the most effect per dollar.
Both drugs work. The real question is value: which one buys you the most weight loss per dollar for your goals? Semaglutide is usually the cheaper molecule; tirzepatide usually loses more weight. Whether the premium is worth it depends on how far you need to go — and how flat the price is.
What the trials actually show
In the STEP-1 trial, once-weekly semaglutide produced roughly 15% average body-weight loss over 68 weeks1. In SURMOUNT-1, tirzepatide reached up to about 21% at its highest dose2. And in a head-to-head diabetes trial, SURPASS-2, tirzepatide beat semaglutide on weight and A1C reduction3. So on raw effect, tirzepatide has the higher ceiling. That is the effectiveness half of "cheaper effective."
The price half
Effect isn't free. Across the cash-pay programs we track, compounded semaglutide typically starts lower than compounded tirzepatide from the same provider — per each provider's published pricing (last reviewed 2026). A program might list semaglutide near $99-$149 flat and tirzepatide $125-$349. That spread is the premium you pay for tirzepatide's higher ceiling. Sometimes it's small (a tight $99/$125 spread is genuinely worth it); sometimes it's large enough to reconsider.
Effect per dollar: how to decide
Frame it as goals, not hype:
- Modest goal, tight budget: semaglutide's ~15% is often more than enough, at the lower price. This is the value pick for most shoppers. - Higher goal or plateaued on semaglutide: tirzepatide's higher ceiling can justify the premium — especially where the spread over semaglutide is small. - Want the option to switch: pick a provider that flat-prices both molecules on one account, so you can step up without changing programs.
Don't let a teaser distort the comparison
Compare the ongoing flat prices, not intro rates. A tirzepatide that advertises a cheap first month and then triples can look competitive with semaglutide when it isn't. We break the pattern down in how to spot a GLP-1 teaser-rate trap. The honest comparison uses the month-twelve price for both.
Verify before you optimize
The cheapest tirzepatide is only a deal if it comes from a verified pharmacy. Compounded versions of both molecules sit outside the FDA-approval process, so pharmacy diligence matters — see is cheap compounded GLP-1 safe?. And if you have insurance, price the brand-name versions too in compounded vs brand-name GLP-1 before defaulting to cash.
The value verdict
For most cash-pay shoppers, semaglutide is the cheaper effective GLP-1 — enough effect, lower price. Tirzepatide earns its premium when your goal is higher or the price spread is thin. To see both molecules priced side by side from verified programs, start with our provider reviews and the compare tools, then pick the smallest price that reaches your goal.
Frequently asked questions
Which loses more weight, semaglutide or tirzepatide?
In trials, tirzepatide has the higher ceiling — up to about 21% average body-weight loss in SURMOUNT-1 versus roughly 15% for semaglutide in STEP-1 — and it outperformed semaglutide head-to-head in the SURPASS-2 diabetes trial.
Which GLP-1 is cheaper?
Semaglutide is usually the lower-priced molecule from the same provider. Tirzepatide typically carries a premium that reflects its higher weight-loss ceiling.
Which is the better value?
For most cash-pay shoppers with a modest goal, semaglutide gives enough effect at a lower price. Tirzepatide earns its premium when your goal is higher or the price spread over semaglutide is small.
References
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Frías JP, Davies MJ, Rosenstock J, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/34170647/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
How to Choose a GLP-1 Provider Without Overpaying
A savings-first checklist for picking a GLP-1 program: read the real 12-month price, verify the pharmacy, match the molecule, and skip teaser bait.
ReadCompounded vs Brand-Name GLP-1: Which Actually Saves You Money
Cash-pay compounded GLP-1 runs $65-$349/mo; brand-name Wegovy and Zepbound list near $1,000+. Here's when each one is actually the cheaper choice.
ReadThe Cheapest Legit Way to Start GLP-1 in 2026
Cash-pay GLP-1 starts as low as $65-$99/mo in 2026 — but 'cheapest' only counts if it's legit. Here's how to get a low price from a verified pharmacy.
ReadHow to Spot a GLP-1 Teaser-Rate Trap
The $99-first-month-then-triples pattern is the most expensive GLP-1 trap. Here's how to spot the teaser rate and price the deal you'll actually pay.
ReadIs Cheap Compounded GLP-1 Safe? How to Vet a Low Price
A low compounded GLP-1 price can be legit or a red flag. Here's how 503A/503B, LegitScript, and FDA compounding rules help you vet the source.
Read